36
Participants
Start Date
February 1, 2017
Primary Completion Date
March 10, 2021
Study Completion Date
March 10, 2021
Bioresorbable Vascular Scaffolds (BVS)
Bioresorbable Vascular Scaffold. Introduced after the interim analysis (phase 2) for comparison with DES-slow.
Drug-Eluting Stent (DES) - slow
"Slow device inflation (mandated in the BVS IFU). To be compared with the DES-std group at interim analysis at the end of phase 1 stage.~After the interim analysis DES-slow to be compared with BVS."
Drug-Eluting Stent (DES) - standard(std)
Metallic DES implanted in standard fashion. To be compared with the DES-slow group at interim analysis at the end of phase 1 stage.
Papworth Hospital NHS Foundation Trust, Cambridge
Papworth Hospital NHS Foundation Trust
OTHER_GOV